BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19221687)

  • 1. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
    Zeymer U; Parhofer KG; Pittrow D; Binz C; Schwertfeger M; Limbourg T; Röther J
    Clin Res Cardiol; 2009 Apr; 98(4):249-56. PubMed ID: 19221687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
    Parhofer KG; Zeymer U; Stark RG; Binz C; Schwertfeger M; Bhatt DL; Steg PG; Röther J;
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):51-6. PubMed ID: 19834877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease.
    Thatipelli MR; Pellikka PA; McBane RD; Rooke TW; Rosales GA; Hodge D; Herges RM; Wysokinski WE
    J Vasc Surg; 2007 Jul; 46(1):62-70; discussion 70. PubMed ID: 17583463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study.
    Moussa ID; Jaff MR; Mehran R; Gray W; Dangas G; Lazic Z; Moses JW
    Catheter Cardiovasc Interv; 2009 May; 73(6):719-24. PubMed ID: 19213068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Feb; 60(2):255-7. PubMed ID: 15814871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
    Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
    CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
    Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ;
    J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic risk factor control in patients with peripheral arterial disease.
    Rehring TF; Sandhoff BG; Stolcpart RS; Merenich JA; Hollis HW
    J Vasc Surg; 2005 May; 41(5):816-22. PubMed ID: 15886666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
    Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The best of vascular medicine in 2006].
    Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.
    Makowsky MJ; McAlister FA; Galbraith PD; Southern DA; Ghali WA; Knudtson ML; Tsuyuki RT;
    Am Heart J; 2008 Feb; 155(2):348-55. PubMed ID: 18215607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients.
    Hasimu B; Li J; Yu J; Ma Y; Zhao M; Nakayama T; Ma W; Yang J; Zheng L; Li X; Luo Y; Xu Y; Zhang L; Zou L; Xiao W; Han Y; Hu D
    Circ J; 2007 Jan; 71(1):95-9. PubMed ID: 17186985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.